Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
Horiot JC, Bontemps P, van den Bogaert W, Le Fur R, van den Weijngaert D, Bolla M, Bernier J, Lusinchi A, Stuschke M, Lopez-Torrecilla J, Begg AC, Pierart M, Collette L. Horiot JC, et al. Among authors: bolla m. Radiother Oncol. 1997 Aug;44(2):111-21. doi: 10.1016/s0167-8140(97)00079-0. Radiother Oncol. 1997. PMID: 9288839 Clinical Trial.
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
Horiot JC, Bontemps P, Begg AC, Le Fur R, Van den Bogaert W, Bolla M, N'Guyen T, Van den Weijngaert D, Bernier J, Lusinchi A, Stuschke D, Lopez Torrecilla D, Jancar B, Collette L, Van Glabbeke M, Pierart M. Horiot JC, et al. Among authors: bolla m. Bull Cancer Radiother. 1996;83(4):314-20. Bull Cancer Radiother. 1996. PMID: 9081333 Clinical Trial. French. No abstract available.
Age is not a limiting factor for radical radiotherapy in pelvic malignancies.
Pignon T, Horiot JC, Bolla M, van Poppel H, Bartelink H, Roelofsen F, Pene F, Gerard A, Einhorn N, Nguyen TD, Vanglabbeke M, Scalliet P. Pignon T, et al. Among authors: bolla m. Radiother Oncol. 1997 Feb;42(2):107-20. doi: 10.1016/s0167-8140(96)01861-0. Radiother Oncol. 1997. PMID: 9106920 Clinical Trial.
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet JM, Bolla M, Coscas Y, Baillet F, Coche-Dequéant B, Urbajtel M, Montbarbon X, Bourdin S, Wibault M, Alfonsi M, Calais G, Desprez P, Pene F, Lapeyre M, Vinke J, Maral J. Horiot JC, et al. Among authors: bolla m. Radiother Oncol. 2000 Jun;55(3):233-9. doi: 10.1016/s0167-8140(99)00018-3. Radiother Oncol. 2000. PMID: 11041775 Clinical Trial.
EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.
Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H. Pavy JJ, et al. Among authors: bolla m. Radiother Oncol. 1995 Apr;35(1):11-5. doi: 10.1016/0167-8140(95)97448-m. Radiother Oncol. 1995. PMID: 7569011 No abstract available.
562 results